AP fact check: COVID-19 vaccine does not spread by inhalation or skin contact
By Arijeta Lajka
Biden administration seeks to increase vaccination ease
The effort comes as the CDC predicts a July turning point in the pandemic if vaccination rates stay on track.
CLAIM: Pfizer admits in its COVID-19 clinical trial protocol document that vaccinated people can shed the vaccine, emitting materials that can spread to unvaccinated people by inhalation or skin contact.
AP’S ASSESSMENT: False. COVID-19 vaccines that are in use, including the Pfizer vaccine, cannot spread between people. Posts making the false claim are misrepresenting standard language in the protocol document intended to protect pregnant women and monitor their potential exposure during clinical trials.
Vaccinated people can t emit vaccine particles for unvaccinated to inhale: Fact check
The Covid-19 vaccine cannot be inhaled via shedding and can only enter the human body through an administered dose.
advertisement
UPDATED: May 9, 2021 09:04 IST
Pfizer’s Covid-19 vaccine does not shed from person to person, nor has the company admitted any such thing. (Photo: Reuters)
CLAIM: Pfizer admits in its Covid-19 clinical trial protocol document that vaccinated people can “shed” the vaccine, emitting materials that can spread to unvaccinated people by inhalation or skin contact.
AP’S ASSESSMENT: False. Covid-19 vaccines that are in use, including the Pfizer vaccine, cannot spread between people. Posts making the false claim are misrepresenting standard language in the protocol document intended to protect pregnant women and monitor their potential exposure during clinical trials.
New Jersey coronavirus update: Rutgers recruiting children for Pfizer s COVID-19 vaccine trial
Replay Video UP NEXT
A university in the Tri-State area has been selected as a clinical trial site for the global Pfizer-BioNTech COVID vaccine study in children.
Rutgers University, the only New Jersey site for the vaccine trial, will enroll as many as 200 kids ages 6 months to 11 years old in the study.
Rutgers will enroll 100 children ages 5 to 12 and 50 children each from the age groups 2 to 5 years and 6 months to 2 years out of 4,644 children worldwide.
This is the third time Rutgers has served as a COVID-19 vaccine clinical trial site for pharmaceutical companies. Last fall, it conducted trials for Moderna and Johnson & Johnson.
Rutgers University
Rutgers, the only New Jersey site for the vaccine trial, will enroll as many as 200 children ages 6 months to 11 years as participants
Rutgers has been selected as a clinical trial site for the global Pfizer-BioNTech research study to evaluate the efficacy of its COVID-19 vaccine in children ages 6 months to 11 years.
This is the third time Rutgers has served as a COVID-19 vaccine clinical trial site for pharmaceutical companies. Last fall, it conducted trials for Moderna and Johnson & Johnson.
The Pediatric Clinical Research Center at Rutgers Robert Wood Johnson Medical School in New Brunswick is one of the several clinical trial sites for Pfizer-BioNTech’s pediatric study. It is the only clinical trial site in New Jersey. Rutgers will enroll up to 100 children ages 5 to 12 and 50 children each from the age groups 2 to 5 years and 6 months to 2 years out of 4,644 children to be enrolled worldwide.
UpdatedFri, May 7, 2021 at 1:25 pm ET
Replies(2)
(Shutterstock/FamVeld)
NEW BRUNSWICK, NJ Rutgers University announced Friday it has been selected as a clinical trial site for the Pfizer-BioNTech vaccine to be tested in children.
The Food & Drug Administration is expected to greenlight the Pfizer vaccine for older kids, ages 12-15, any day now. What Rutgers is involved in is a third Pfizer coronavirus vaccine trial, where the shot is currently being tested in children six months to under 12 years old.
Rutgers will test 200 children total in its trial. There will be 100 children in the 5-11 group, which will be tested first, followed by 50 children ages 2 to 5, and 50 children 6 months to 2 years.